← Back to headlines





Weight-Loss Drug Semaglutide Approved in Tablet Form Across EU
The active ingredient Semaglutide, used in weight-loss medication, has received EU-wide approval for its tablet form, offering an alternative to injections.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories

Lionel Richie Hospitalized in ICU Following St. Louis Concert
1h ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
9h ago

Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
11h ago

England Pharmacies to Offer Free Quick Cholesterol Screening Tests
19h ago